339 related articles for article (PubMed ID: 12823096)
1. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.
Jasmin JF; Cernacek P; Dupuis J
Clin Sci (Lond); 2003 Dec; 105(6):647-53. PubMed ID: 12823096
[TBL] [Abstract][Full Text] [Related]
2. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
Prié S; Leung TK; Cernacek P; Ryan JW; Dupuis J
J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
[TBL] [Abstract][Full Text] [Related]
3. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
[TBL] [Abstract][Full Text] [Related]
4. Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat.
Brunner F
Cardiovasc Res; 1999 Oct; 44(1):197-206. PubMed ID: 10615403
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
6. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of a nonselective ET(A/B) and a selective ET(A) antagonist in rats with monocrotaline-induced pulmonary hypertension.
Jasmin JF; Lucas M; Cernacek P; Dupuis J
Circulation; 2001 Jan; 103(2):314-8. PubMed ID: 11208695
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 is elevated in monocrotaline pulmonary hypertension.
Frasch HF; Marshall C; Marshall BE
Am J Physiol; 1999 Feb; 276(2):L304-10. PubMed ID: 9950893
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension.
Kosanovic D; Kojonazarov B; Luitel H; Dahal BK; Sydykov A; Cornitescu T; Janssen W; Brandes RP; Davie N; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Schermuly RT
Respir Res; 2011 Jun; 12():87. PubMed ID: 21699729
[TBL] [Abstract][Full Text] [Related]
10. Roles of endothelin ETA and ETB receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension.
Nishida M; Eshiro K; Okada Y; Takaoka M; Matsumura Y
J Cardiovasc Pharmacol; 2004 Aug; 44(2):187-91. PubMed ID: 15243299
[TBL] [Abstract][Full Text] [Related]
11. Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080).
Brunner F; Wölkart G; Haleen S
J Pharmacol Exp Ther; 2002 Feb; 300(2):442-9. PubMed ID: 11805203
[TBL] [Abstract][Full Text] [Related]
12. Role of endothelin ETB receptor in the pathogenesis of monocrotaline-induced pulmonary hypertension in rats.
Nishida M; Okada Y; Akiyoshi K; Eshiro K; Takoaka M; Gariepy CE; Yanagisawa M; Matsumura Y
Eur J Pharmacol; 2004 Aug; 496(1-3):159-65. PubMed ID: 15359489
[TBL] [Abstract][Full Text] [Related]
13. EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension.
Prié S; Stewart DJ; Dupuis J
Circulation; 1998 Jun; 97(21):2169-74. PubMed ID: 9626178
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
15. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
Tilton RG; Munsch CL; Sherwood SJ; Chen SJ; Chen YF; Wu C; Block N; Dixon RA; Brock TA
Pulm Pharmacol Ther; 2000; 13(2):87-97. PubMed ID: 10799286
[TBL] [Abstract][Full Text] [Related]
17. YM598, an orally active ET(A) receptor antagonist, ameliorates the progression of cardiopulmonary changes and both-side heart failure in rats with cor pulmonale and myocardial infarction.
Fujimori A; Miyauchi T; Sakai S; Yuyama H; Iemitsu M; Sanagi M; Sudoh K; Goto K; Shikama H; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S354-7. PubMed ID: 15838319
[TBL] [Abstract][Full Text] [Related]
18. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
19. Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: role of ETB-receptor expression levels.
Sauvageau S; Thorin E; Villeneuve L; Dupuis J
Pulm Pharmacol Ther; 2009 Aug; 22(4):311-7. PubMed ID: 19489130
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
